ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,212.20
0.10%
S&P ASX All Technology
3,444.90
0.35%
Brent Oil
71.155
0.29%
US Dollar vs AUD
1.45027
-0.04%
Bitcoin
65,456.59
0.42%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Labcorp Holdings Inc (LH)

  7. Labcorp Holdings Inc (LH) News

LH

Labcorp (LH)

Labcorp Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:LH
DateTimeSourceHeadlineSymbolCompany
25/09/202406:21Edgar (US Regulatory)Form 8-K - Current reportNYSE:LHLabcorp Holdings Inc
25/09/202406:16PR Newswire (US)Labcorp to Announce Third Quarter Financial Results on October 24, 2024NYSE:LHLabcorp Holdings Inc
24/09/202406:18Edgar (US Regulatory)Form 8-K - Current reportNYSE:LHLabcorp Holdings Inc
19/09/202406:05Edgar (US Regulatory)Form 8-K - Current reportNYSE:LHLabcorp Holdings Inc
18/09/202421:00PR Newswire (US)Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum ExperienceNYSE:LHLabcorp Holdings Inc
18/09/202420:12Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:LHLabcorp Holdings Inc
17/09/202408:35PR Newswire (US)LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034NYSE:LHLabcorp Holdings Inc
17/09/202407:30Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:LHLabcorp Holdings Inc
16/09/202422:21Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NYSE:LHLabcorp Holdings Inc
16/09/202421:30PR Newswire (US)Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO HealthNYSE:LHLabcorp Holdings Inc
04/09/202406:09PR Newswire (US)Labcorp to Speak at the Baird 2024 Global Healthcare ConferenceNYSE:LHLabcorp Holdings Inc
10/08/202400:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LHLabcorp Holdings Inc
05/08/202421:00PR Newswire (US)Labcorp Finalizes Acquisition of Select Assets of InvitaeNYSE:LHLabcorp Holdings Inc
02/08/202422:30PR Newswire (US)Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus DxNYSE:LHLabcorp Holdings Inc
01/08/202420:57PR Newswire (US)Labcorp Announces 2024 Second Quarter ResultsNYSE:LHLabcorp Holdings Inc
30/07/202421:00PR Newswire (US)Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing CapabilitiesNYSE:LHLabcorp Holdings Inc
25/07/202420:59PR Newswire (US)Labcorp Declares Quarterly DividendNYSE:LHLabcorp Holdings Inc
01/07/202421:00PR Newswire (US)Labcorp to Announce Second Quarter Financial Results on August 1, 2024NYSE:LHLabcorp Holdings Inc
17/06/202422:00PR Newswire (US)Labcorp Launches Global Trial Connect to Accelerate Clinical TrialsNYSE:LHLabcorp Holdings Inc
10/06/202422:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LHLabcorp Holdings Inc
04/06/202421:41Edgar (US Regulatory)Form 8-K - Current reportNYSE:LHLabcorp Holdings Inc
04/06/202407:23Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NYSE:LHLabcorp Holdings Inc
03/06/202421:00PR Newswire (US)Labcorp Announces New Strategic Service Offerings within Precision Oncology PortfolioNYSE:LHLabcorp Holdings Inc
31/05/202403:18Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:LHLabcorp Holdings Inc
30/05/202421:00PR Newswire (US)Labcorp to Present Multiple Abstracts across Precision Oncology at the 2024 ASCO Annual MeetingNYSE:LHLabcorp Holdings Inc
28/05/202421:04Edgar (US Regulatory)Form 8-K - Current reportNYSE:LHLabcorp Holdings Inc
28/05/202420:59PR Newswire (US)Labcorp to Speak at the 44th Annual William Blair Growth Stock ConferenceNYSE:LHLabcorp Holdings Inc
18/05/202406:57Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:LHLabcorp Holdings Inc
18/05/202406:45Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNYSE:LHLabcorp Holdings Inc
18/05/202406:41Edgar (US Regulatory)Form POSASR - Post-effective Amendment to an automatic shelf registration statementNYSE:LHLabcorp Holdings Inc
 Showing the most relevant articles for your search:NYSE:LH

Your Recent History

ASX
BMBDA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved